EE147 A Cost-Effectiveness Analysis of Pemigatinib Versus Gemcitabine/Cisplatin Therapy in Patients with Cholangiocarcinoma
Jun 1, 2023, 00:00
10.1016/j.jval.2023.03.450
https://www.valueinhealthjournal.com/article/S1098-3015(23)00550-8/fulltext
Title :
EE147 A Cost-Effectiveness Analysis of Pemigatinib Versus Gemcitabine/Cisplatin Therapy in Patients with Cholangiocarcinoma
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)00550-8&doi=10.1016/j.jval.2023.03.450
First page :
Section Title :
Open access? :
No
Section Order :
11832